SNAP-8

SNAP-8 is an eight-amino-acid synthetic peptide and extended derivative of Argireline (Acetyl Hexapeptide-3). It is engineered to attenuate neuromuscular signaling that drives repetitive facial muscle contractions, reducing the appearance of expression lines and dynamic wrinkles. Developed as a non-invasive topical alternative to botulinum toxin injections, SNAP-8 is approximately 30% more active than its parent compound Argireline.

SNAP-8 mimics the N-terminal end of SNAP-25, a protein integral to the SNARE complex responsible for vesicular release of acetylcholine at the neuromuscular junction. By competing with endogenous SNAP-25 for a position in the SNARE complex, SNAP-8 partially destabilizes complex formation. This reduces efficiency of neurotransmitter release, attenuating the signal that drives facial muscle contraction. The result is a mild, reversible reduction in the intensity of expression-driven muscle movement, which over time diminishes the depth of dynamic wrinkles without paralysis.

A 28-day topical clinical study demonstrated wrinkle depth reductions of approximately 63% versus baseline, surpassing the efficacy reported for Argireline. In vitro data show SNAP-8 is roughly 30% more potent than hexapeptide formulations targeting the SNARE pathway. No independent peer-reviewed RCTs published as of 2026; most evidence is from cosmetic ingredient supplier studies. Considered safe for cosmetic use by EU regulatory assessments.

Peptides commonly paired with SNAP-8 for synergistic effects.